| |
| |
|
| Insider
Information: |
Venkataraman Ganesh |
| Relationship: |
COO & CSO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
495,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,985,210 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
495,145 |
|
|
| Total
Value |
$25,985,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
COO & CSO |
2018-08-21 |
495,145 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
173 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-08-20 |
4 |
AS |
$14.47 |
$3,140 |
D/D |
(217) |
424,986 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-11-15 |
4 |
AS |
$16.88 |
$3,663 |
D/D |
(217) |
424,557 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-11-19 |
4 |
AS |
$17.17 |
$3,726 |
D/D |
(217) |
424,340 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-18 |
4 |
AS |
$17.96 |
$3,897 |
D/D |
(217) |
345,912 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-19 |
4 |
AS |
$17.86 |
$3,876 |
D/D |
(217) |
365,007 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-05-15 |
4 |
AS |
$11.09 |
$2,407 |
D/D |
(217) |
394,875 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-08-15 |
4 |
AS |
$11.75 |
$2,550 |
D/D |
(217) |
394,220 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-11-17 |
4 |
AS |
$10.64 |
$2,309 |
D/D |
(217) |
393,564 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-08-15 |
4 |
AS |
$15.43 |
$3,364 |
D/D |
(218) |
425,203 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-05-20 |
4 |
AS |
$12.08 |
$2,742 |
D/D |
(227) |
394,648 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-02-20 |
4 |
AS |
$13.40 |
$3,042 |
D/D |
(227) |
436,809 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-05-20 |
4 |
AS |
$19.68 |
$4,467 |
D/D |
(227) |
388,785 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-11-20 |
4 |
AS |
$17.75 |
$4,029 |
D/D |
(227) |
387,105 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-02-22 |
4 |
AS |
$9.65 |
$2,191 |
D/D |
(227) |
403,368 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-05-20 |
4 |
AS |
$10.11 |
$2,295 |
D/D |
(227) |
456,112 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-08-22 |
4 |
AS |
$12.10 |
$2,747 |
D/D |
(227) |
455,063 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-11-22 |
4 |
AS |
$14.40 |
$3,269 |
D/D |
(227) |
454,015 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-08-20 |
4 |
AS |
$11.54 |
$2,631 |
D/D |
(228) |
393,992 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-11-20 |
4 |
AS |
$11.13 |
$2,538 |
D/D |
(228) |
393,336 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-08-20 |
4 |
AS |
$22.20 |
$5,062 |
D/D |
(228) |
387,945 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-02-18 |
4 |
AS |
$11.91 |
$3,001 |
D/D |
(252) |
438,621 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2016-02-18 |
4 |
AS |
$10.49 |
$2,853 |
D/D |
(272) |
405,733 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
COO & CSO |
• – – |
2018-02-12 |
4 |
AS |
$16.20 |
$5,524 |
D/D |
(341) |
500,690 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
COO & CSO |
• – – |
2018-05-10 |
4 |
AS |
$21.95 |
$7,726 |
D/D |
(352) |
495,864 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2017-05-10 |
4 |
AS |
$16.00 |
$6,144 |
D/D |
(384) |
490,453 |
0 |
- |
|
173 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
